Episode Details

Back to Episodes

Neuralink: The Biological Margin Call

Season 1 Published 5 months, 4 weeks ago
Description

Cassandra warned of the horse; we warn of the wire. Neuralink boasts a staggering nine-billion-dollar valuation as of Q1 2026, a figure our empirical analyst, Katie, hails as a triumph of neurotechnology and institutional confidence. But Marcus, our cynical auditor, sees a "rusted spark plug in a flooded engine" – a speculative bubble built on the "capitalization of the mind." Join us as we dissect this monumental valuation, questioning whether it's a miracle of innovation or a ticking biological time bomb, stripping copper from your own walls to pay the electric bill.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us